Tafinlar and Mekinist approved in Japan as adjuvant therapy for BRAF mutation-positive melanoma July 3, 2018
FDA grants priority review to sBLA for Keytruda with chemotherapy in first-line metastatic NSCLC July 3, 2018
RSS